Terms: = Breast cancer AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2
44 results:
1. Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.
Mehra T; Lupatsch JE; Kössler T; Dedes K; Siebenhüner AR; von Moos R; Wicki A; Schwenkglenks ME
PLoS One; 2024; 19(4):e0301271. PubMed ID: 38573891
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the resistance mechanism of triple-negative breast cancer to paclitaxel through the scRNA-seq analysis.
Gao W; Sun L; Gai J; Cao Y; Zhang S
PLoS One; 2024; 19(1):e0297260. PubMed ID: 38227591
[TBL] [Abstract] [Full Text] [Related]
3. Copy number variants landscape of multiple cancers and clinical applications based on NGS gene panel.
Yan K; Niu L; Wu B; He C; Deng L; Chen C; Lan Z; Lin C; Kuang W; Lin H; Zou J; Zhang W; Luo Z
Ann Med; 2023; 55(2):2280708. PubMed ID: 37967237
[TBL] [Abstract] [Full Text] [Related]
4.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
5. PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway.
Zhang R; Dong M; Tu J; Li F; Deng Q; Xu J; He X; Ding J; Xia J; Sheng D; Chang Z; Ma W; Dong H; Zhang Y; Zhang L; Zhang L; Liu S
Signal Transduct Target Ther; 2023 Mar; 8(1):97. PubMed ID: 36859354
[TBL] [Abstract] [Full Text] [Related]
6. Design, synthesis and SAR study of Fluorine-containing 3rd-generation taxoids.
Wang C; Chen L; Sun Y; Guo W; Taouil AK; Ojima I
Bioorg Chem; 2022 Feb; 119():105578. PubMed ID: 34979464
[TBL] [Abstract] [Full Text] [Related]
7. NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer.
Pappas K; Martin TC; Wolfe AL; Nguyen CB; Su T; Jin J; Hibshoosh H; Parsons R
Commun Biol; 2021 Mar; 4(1):312. PubMed ID: 33750924
[TBL] [Abstract] [Full Text] [Related]
8. Causal Bayesian gene networks associated with bone, brain and lung metastasis of breast cancer.
Park SB; Hwang KT; Chung CK; Roy D; Yoo C
Clin Exp Metastasis; 2020 Dec; 37(6):657-674. PubMed ID: 33083937
[TBL] [Abstract] [Full Text] [Related]
9. 3-O-(E)-p-Coumaroyl betulinic acid possess anticancer activity and inhibit Notch signaling pathway in breast cancer cells and mammosphere.
Kushwaha PP; Singh AK; Shuaib M; Prajapati KS; Vardhan PS; Gupta S; Kumar S
Chem Biol Interact; 2020 Sep; 328():109200. PubMed ID: 32702347
[TBL] [Abstract] [Full Text] [Related]
10. Design, synthesis and SAR study of 3rd-generation taxoids bearing 3-CH
Wang C; Wang X; Sun Y; Taouil AK; Yan S; Botchkina GI; Ojima I
Bioorg Chem; 2020 Jan; 95():103523. PubMed ID: 31911305
[TBL] [Abstract] [Full Text] [Related]
11. Bulbine frutescens phytochemical inhibits notch signaling pathway and induces apoptosis in triple negative and luminal breast cancer cells.
Kushwaha PP; Vardhan PS; Kapewangolo P; Shuaib M; Prajapati SK; Singh AK; Kumar S
Life Sci; 2019 Oct; 234():116783. PubMed ID: 31442552
[TBL] [Abstract] [Full Text] [Related]
12. Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2.
Xiu DH; Liu GF; Yu SN; Li LY; Zhao GQ; Liu L; Li XF
J Exp Clin Cancer Res; 2019 Feb; 38(1):94. PubMed ID: 30791958
[TBL] [Abstract] [Full Text] [Related]
13. Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.
Chen JH; Kuo KT; Bamodu OA; Lin YC; Yang RB; Yeh CT; Chao TY
Exp Cell Res; 2018 Sep; 370(2):444-453. PubMed ID: 29981340
[TBL] [Abstract] [Full Text] [Related]
14. Modification of α2,6-sialylation mediates the invasiveness and tumorigenicity of non-small cell lung cancer cells in vitro and in vivo via Notch1/Hes1/MMPs pathway.
Yuan Q; Chen X; Han Y; Lei T; Wu Q; Yu X; Wang L; Fan Z; Wang S
Int J Cancer; 2018 Nov; 143(9):2319-2330. PubMed ID: 29981167
[TBL] [Abstract] [Full Text] [Related]
15. hey1- and p53-dependent TrkC proapoptotic activity controls neuroblastoma growth.
Ménard M; Costechareyre C; Ichim G; Blachier J; Neves D; Jarrosson-Wuilleme L; Depping R; Koster J; Saintigny P; Mehlen P; Tauszig-Delamasure S
PLoS Biol; 2018 May; 16(5):e2002912. PubMed ID: 29750782
[TBL] [Abstract] [Full Text] [Related]
16. The adaptor SASH1 acts through NOTCH1 and its inhibitor DLK1 in a 3D model of lumenogenesis involving CEACAM1.
Stubblefield K; Chean J; Nguyen T; Chen CJ; Shively JE
Exp Cell Res; 2017 Oct; 359(2):384-393. PubMed ID: 28823832
[TBL] [Abstract] [Full Text] [Related]
17. Syndecan-1 is a novel molecular marker for triple negative inflammatory breast cancer and modulates the cancer stem cell phenotype via the IL-6/STAT3, Notch and EGFR signaling pathways.
Ibrahim SA; Gadalla R; El-Ghonaimy EA; Samir O; Mohamed HT; Hassan H; Greve B; El-Shinawi M; Mohamed MM; Götte M
Mol Cancer; 2017 Mar; 16(1):57. PubMed ID: 28270211
[TBL] [Abstract] [Full Text] [Related]
18. [HIF-2α/Notch3 pathway mediates CoCl
Wang JG; Yuan L
Sheng Li Xue Bao; 2016 Dec; 68(6):783-789. PubMed ID: 28004073
[TBL] [Abstract] [Full Text] [Related]
19. The V-ATPase a2 isoform controls mammary gland development through Notch and TGF-β signaling.
Pamarthy S; Mao L; Katara GK; Fleetwood S; Kulshreshta A; Gilman-Sachs A; Beaman KD
Cell Death Dis; 2016 Nov; 7(11):e2443. PubMed ID: 27809299
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
[TBL] [Abstract] [Full Text] [Related]
[Next]